Christine A. Pellizzari J.D.
Net Worth
Last updated:
What is Christine A. Pellizzari J.D. net worth?
The estimated net worth of Ms. Christine A. Pellizzari J.D. is at least $25,087,414 as of 9 Feb 2021. She owns shares worth $17,930,670 as insider, has earned $561,094 from insider trading and has received compensation worth at least $6,595,650 in Insmed Incorporated.
What is the salary of Christine A. Pellizzari J.D.?
Ms. Christine A. Pellizzari J.D. salary is $732,850 per year as Consultant in Insmed Incorporated.
How old is Christine A. Pellizzari J.D.?
Ms. Christine A. Pellizzari J.D. is 57 years old, born in 1968.
What stocks does Christine A. Pellizzari J.D. currently own?
As insider, Ms. Christine A. Pellizzari J.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Insmed Incorporated (INSM) | Consultant | 140,721 | $127.42 | $17,930,670 |
What does Insmed Incorporated do?
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Christine A. Pellizzari J.D. insider trading
Insmed Incorporated
Ms. Christine A. Pellizzari J.D. has made 8 insider trades between 2016-2021, according to the Form 4 filled with the SEC. Most recently she sold 15,150 units of INSM stock on 9 Feb 2021.
The largest trade she's ever made was exercising 114,096 units of INSM stock on 3 Nov 2020. As of 9 Feb 2021 she still owns at least 140,721 units of INSM stock.
Insmed Incorporated key executives
Insmed Incorporated executives and other stock owners filed with the SEC:
- Dr. Martina Flammer M.B.A., M.D. (61) Chief Medical Officer
- Mr. Roger Adsett (56) Chief Operating Officer
- Mr. William H. Lewis J.D., M.B.A. (56) Pres, Chief Executive Officer & Chairman
- Ms. Christine A. Pellizzari J.D. (57) Consultant
- Ms. Sara M. Bonstein MBA (44) Chief Financial Officer